AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024

Rhea-AI Summary

Amgen (NASDAQ: AMGN) will host a conference call for investors on May 20, 2024, at 1:00 p.m. PT, following the presentation of new data on TEZSPIRE® for chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS) International Conference. The presentation will be held on May 19-20, 2024, and also include updates on Amgen's inflammation portfolio. Jay Bradner, EVP of R&D and Chief Scientific Officer, along with other team members, will participate. The webcast will be accessible online, including media, investors, and the public, and will be archived for 90 days on Amgen's website.

Positive

• Amgen will present new data on TEZSPIRE® for COPD at the ATS International Conference.
• The presentation will include updates on Amgen's inflammation portfolio.
• Jay Bradner, EVP of R&D and Chief Scientific Officer, will participate in the call.
• The webcast will be available to media, investors, and the general public.
• The webcast will be archived for 90 days, allowing for extended access.

Negative

• No specific financial data or performance metrics were mentioned in the press release.
• Potential negative outcomes of the TEZSPIRE® data presentation were not discussed.
• The webcast's impact on stock performance is uncertain without clear clinical trial outcomes.

THOUSAND OAKS, Calif., May 15, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcasted call for the investment community at 1:00 p.m. PT on Monday, May 20, 2024 following the presentation of new data from TEZSPIRE^® in chronic obstructive pulmonary disease (COPD) at the American Thoracic Society (ATS) International Conference on May 19 and 20, 2024. The presentation will also include an overview of additional programs from Amgen's innovative inflammation portfolio. Jay Bradner, executive vice president of Research and Development and chief scientific officer at Amgen, and other members of the Amgen team will participate. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.

In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average^®, and it is also part of the Nasdaq-100 Index^®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.

For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 

CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Justin Claeys, 805-313-9775 (investors)  

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-host-conference-call-following-ats-2024-302146981.html

SOURCE Amgen

FAQ

When is Amgen hosting its webcasted conference call?

Amgen will host its webcasted conference call on May 20, 2024, at 1:00 p.m. PT.

What will Amgen present at the ATS International Conference?

Amgen will present new data on TEZSPIRE® for COPD and updates on its inflammation portfolio.

Who will participate in the Amgen conference call?

Jay Bradner, EVP of R&D and Chief Scientific Officer, along with other Amgen team members, will participate.

Where can investors access the Amgen webcast?

Investors can access the Amgen webcast on Amgen's website under the Investors section.

How long will the Amgen webcast be available for replay?

The Amgen webcast will be archived and available for replay for at least 90 days.